ClearPoint Neuro Inc. (CLPT)
ClearPoint Neuro Statistics
Share Statistics
ClearPoint Neuro has 27.58M shares outstanding. The number of shares has increased by 2.26% in one year.
| Shares Outstanding | 27.58M |
| Shares Change (YoY) | 2.26% |
| Shares Change (QoQ) | -0.04% |
| Owned by Institutions (%) | 24.74% |
| Shares Floating | 23.94M |
| Failed to Deliver (FTD) Shares | 21 |
| FTD / Avg. Volume | 0.01% |
Short Selling Information
The latest short interest is 838.64K, so 3.04% of the outstanding shares have been sold short.
| Short Interest | 838.64K |
| Short % of Shares Out | 3.04% |
| Short % of Float | 3.51% |
| Short Ratio (days to cover) | 4.09 |
Valuation Ratios
The PE ratio is -21.98 and the forward PE ratio is -30.75. ClearPoint Neuro's PEG ratio is 0.99.
| PE Ratio | -21.98 |
| Forward PE | -30.75 |
| PS Ratio | 13.24 |
| Forward PS | 6.2 |
| PB Ratio | 16.37 |
| P/FCF Ratio | -45.06 |
| PEG Ratio | 0.99 |
Enterprise Valuation
ClearPoint Neuro Inc. has an Enterprise Value (EV) of 157.87M.
| EV / Earnings | -8.35 |
| EV / Sales | 5.03 |
| EV / EBITDA | -8 |
| EV / EBIT | -8 |
| EV / FCF | -17.11 |
Financial Position
The company has a current ratio of 3.22, with a Debt / Equity ratio of 0.14.
| Current Ratio | 3.22 |
| Quick Ratio | 2.56 |
| Debt / Equity | 0.14 |
| Total Debt / Capitalization | 12.32 |
| Cash Flow / Debt | -2.51 |
| Interest Coverage | 0 |
Financial Efficiency
Return on equity (ROE) is -0.74% and return on capital (ROIC) is -68.19%.
| Return on Equity (ROE) | -0.74% |
| Return on Assets (ROA) | -0.48% |
| Return on Capital (ROIC) | -68.19% |
| Revenue Per Employee | $293,364.49 |
| Profits Per Employee | $-176,766.36 |
| Employee Count | 107 |
| Asset Turnover | 0.8 |
| Inventory Turnover | 1.79 |
Taxes
| Income Tax | 0 |
| Effective Tax Rate | 0 |
Stock Price Statistics
The stock price has increased by 117.37% in the last 52 weeks. The beta is 1.03, so ClearPoint Neuro's price volatility has been higher than the market average.
| Beta | 1.03 |
| 52-Week Price Change | 117.37% |
| 50-Day Moving Average | 16.6 |
| 200-Day Moving Average | 11.45 |
| Relative Strength Index (RSI) | 35.57 |
| Average Volume (20 Days) | 233.27K |
Income Statement
In the last 12 months, ClearPoint Neuro had revenue of 31.39M and earned -18.91M in profits. Earnings per share was -0.7.
| Revenue | 31.39M |
| Gross Profit | 19.12M |
| Operating Income | -19.75M |
| Net Income | -18.91M |
| EBITDA | -19.75M |
| EBIT | -19.75M |
| Earnings Per Share (EPS) | -0.7 |
Balance Sheet
The company has 20.1M in cash and 3.57M in debt, giving a net cash position of 16.54M.
| Cash & Cash Equivalents | 20.1M |
| Total Debt | 3.57M |
| Net Cash | 16.54M |
| Retained Earnings | -191.37M |
| Total Assets | 39.19M |
| Working Capital | 23.01M |
Cash Flow
In the last 12 months, operating cash flow was -8.95M and capital expenditures -275K, giving a free cash flow of -9.22M.
| Operating Cash Flow | -8.95M |
| Capital Expenditures | -275K |
| Free Cash Flow | -9.22M |
| FCF Per Share | -0.34 |
Margins
Gross margin is 60.92%, with operating and profit margins of -62.91% and -60.25%.
| Gross Margin | 60.92% |
| Operating Margin | -62.91% |
| Pretax Margin | -60.25% |
| Profit Margin | -60.25% |
| EBITDA Margin | -62.91% |
| EBIT Margin | -62.91% |
| FCF Margin | -29.39% |
Dividends & Yields
CLPT does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Payout Ratio | n/a |
| Earnings Yield | -4.82% |
| FCF Yield | -2.3% |
Analyst Forecast
The average price target for CLPT is $20, which is 37.7% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $20 |
| Price Target Difference | 37.7% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 3 |
Stock Splits
The last stock split was on Jul 27, 2016. It was a backward split with a ratio of 1:40.
| Last Split Date | Jul 27, 2016 |
| Split Type | backward |
| Split Ratio | 1:40 |
Scores
| Altman Z-Score | 13.72 |
| Piotroski F-Score | 3 |